|
US2086186A
(en)
|
1933-10-10 |
1937-07-06 |
Us Rubber Co |
Treatment of rubber
|
|
GB1435721A
(en)
|
1972-05-18 |
1976-05-12 |
Lilly Industries Ltd |
Benzoxazole derivatives
|
|
SU509046A1
(ru)
|
1975-02-21 |
1984-06-23 |
Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе |
Производные 2-карбэтокси-3-аминоиндола,про вл ющие противовоспалительную активность, и способ их получени
|
|
US4675332A
(en)
|
1984-12-10 |
1987-06-23 |
Warner-Lambert Company |
Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents
|
|
GB8610981D0
(en)
|
1986-05-06 |
1986-06-11 |
Ici America Inc |
Quinoline amides
|
|
NZ225045A
(en)
|
1987-07-01 |
1990-06-26 |
Janssen Pharmaceutica Nv |
Antiviral pharmaceutical compositions containing cyclodextrin and an antiviral agent
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
AU8942491A
(en)
|
1990-10-22 |
1992-05-20 |
Bausch & Lomb Incorporated |
Method and composition for cleaning contact lenses
|
|
AU641052B2
(en)
|
1990-11-02 |
1993-09-09 |
Aventisub Ii Inc. |
3-amidoindolyl derivatives
|
|
US5668117A
(en)
|
1991-02-22 |
1997-09-16 |
Shapiro; Howard K. |
Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
|
|
US6444221B1
(en)
|
1992-06-30 |
2002-09-03 |
Howard K. Shapiro |
Methods of treating chronic inflammatory diseases using carbonyl trapping agents
|
|
US20050090553A1
(en)
|
1992-06-30 |
2005-04-28 |
Shapiro Howard K. |
Compositions and method for treatment of chronic inflammatory diseases
|
|
US5472954A
(en)
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
|
TW401300B
(en)
|
1992-12-25 |
2000-08-11 |
Senju Pharma Co |
Antiallergic composition for ophthalmic or nasal use
|
|
US5493027A
(en)
|
1993-01-22 |
1996-02-20 |
Board Of Regents, The University Of Texas System |
Anticonvulsive agents and uses thereof
|
|
US5767109A
(en)
|
1993-10-20 |
1998-06-16 |
Sanchez; Robert A. |
Complexing urushiols
|
|
US5576311A
(en)
|
1994-11-30 |
1996-11-19 |
Pharmos Corporation |
Cyclodextrins as suspending agents for pharmaceutical suspensions
|
|
JP3297969B2
(ja)
|
1994-12-26 |
2002-07-02 |
ライオン株式会社 |
点眼剤
|
|
US5597823A
(en)
|
1995-01-27 |
1997-01-28 |
Abbott Laboratories |
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
|
|
JP3736916B2
(ja)
|
1996-02-19 |
2006-01-18 |
株式会社サンコンタクトレンズ |
含水性ソフトコンタクトレンズの消毒用組成物とその用途
|
|
CA2261916A1
(en)
|
1996-08-01 |
1998-02-12 |
Dowelanco Llc |
4-substituted quinoline derivatives having fungicidal activity
|
|
US6191127B1
(en)
|
1997-05-02 |
2001-02-20 |
Schering Aktiengesellschaft |
Substituted heterocycles and their use in medicaments
|
|
GB2327672A
(en)
|
1997-07-23 |
1999-02-03 |
Merck & Co Inc |
4-(1,2,3,4-Tetrahydro-1,8-naphthyridin-7-yl)butanoyl-glycyl-3(S)-quinolin-3-yl-beta-alanine
|
|
EP1080068A1
(en)
|
1998-03-12 |
2001-03-07 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases
|
|
US6498154B1
(en)
|
1999-05-04 |
2002-12-24 |
Wyeth |
Cyclic regimens using quinazolinone and benzoxazine derivatives
|
|
US6358948B1
(en)
|
1999-05-04 |
2002-03-19 |
American Home Products Corporation |
Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
|
|
EP1233768A1
(en)
|
1999-11-15 |
2002-08-28 |
Smithkline Beecham |
Carvedilol methanesulfonate
|
|
AU1735001A
(en)
|
1999-12-10 |
2001-06-18 |
Senju Pharmaceutical Co., Ltd. |
Cyclodextrin-containing pharmaceutical composition
|
|
US6569879B2
(en)
|
2000-02-18 |
2003-05-27 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
JP4748289B2
(ja)
|
2000-06-23 |
2011-08-17 |
ライオン株式会社 |
点眼剤、眼科用組成物及び吸着抑制方法
|
|
FR2827599A1
(fr)
|
2001-07-20 |
2003-01-24 |
Neuro3D |
Composes derives de quinoleine et quinoxaline,preparation et utilisations
|
|
UA83620C2
(ru)
|
2001-12-05 |
2008-08-11 |
Уайт |
Замещенные бензоксазолы и их аналоги как эстрогенные агенты
|
|
US20060014786A1
(en)
|
2002-05-17 |
2006-01-19 |
Rajeev Raut |
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
US20040198828A1
(en)
|
2003-01-17 |
2004-10-07 |
Abelson Mark B. |
Combinational use of long-acting and short-acting anti-histamines for ocular allergies
|
|
US20060281821A1
(en)
|
2003-03-14 |
2006-12-14 |
Krzysztof Palczewski |
Retinoid replacements and opsin agonists and methods for the use thereof
|
|
US20060111318A1
(en)
|
2003-04-18 |
2006-05-25 |
Advanced Medicine Research Institute |
Agent for treating eye diseases
|
|
EP1621199B8
(en)
|
2003-04-18 |
2011-01-19 |
Advanced Medicine Research Institute |
Remedies for diseases to be applied to eye
|
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
|
US20040235892A1
(en)
|
2003-05-22 |
2004-11-25 |
Yujia Dai |
Indazole and benzisoxazole kinase inhibitors
|
|
US7083803B2
(en)
|
2003-09-19 |
2006-08-01 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
JP4110324B2
(ja)
|
2003-10-15 |
2008-07-02 |
宇部興産株式会社 |
新規インダゾール誘導体
|
|
KR20060123208A
(ko)
|
2003-10-27 |
2006-12-01 |
아스테라스 세이야쿠 가부시키가이샤 |
피라진 유도체 및 이의 약학적 용도
|
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US20050197292A1
(en)
|
2004-01-30 |
2005-09-08 |
Glennda Smithson |
Compositions and methods for treating T-cell mediated pathological conditions
|
|
US20080176952A1
(en)
|
2004-02-17 |
2008-07-24 |
Rando Robert R |
Management of Ophthalmologic Disorders, Including Macular Degeneration
|
|
US20050234018A1
(en)
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
|
WO2006002473A1
(en)
|
2004-07-02 |
2006-01-12 |
Adelaide Research & Innovation Pty Ltd |
Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
|
|
JP2008518913A
(ja)
|
2004-10-28 |
2008-06-05 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体のピリミジン及びキノリン増強因子
|
|
US20100160304A1
(en)
|
2005-01-19 |
2010-06-24 |
Dainippon Sumitomo Pharma Co., Ltd |
Aromatic sulfone compound as aldosterone receptor modulator
|
|
TW200640443A
(en)
|
2005-02-23 |
2006-12-01 |
Alcon Inc |
Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
|
|
ES2393768T3
(es)
|
2005-05-26 |
2012-12-27 |
Neuron Systems, Inc |
Derivado de quinolina para el tratamiento de enfermedades retinianas
|
|
JP4466875B2
(ja)
|
2006-04-05 |
2010-05-26 |
ライオン株式会社 |
ソフトコンタクトレンズ用点眼剤
|
|
ES2437997T3
(es)
|
2006-04-14 |
2014-01-15 |
Prana Biotechnology Limited |
Método de tratamiento de la degeneración macular relacionada con la edad (AMD)
|
|
JP5194218B2
(ja)
|
2006-06-05 |
2013-05-08 |
株式会社メニコンネクト |
含水性コンタクトレンズの保存方法ならびに該保存方法により保存された含水性コンタクトレンズ
|
|
CA2658793A1
(en)
|
2006-07-25 |
2008-02-07 |
Daniel Dumas |
Quinoline derivatives
|
|
US8158609B1
(en)
|
2006-11-02 |
2012-04-17 |
Novartis Ag |
Use of cyclodextrins as an active ingredient for treating dry AMD and solubilizing drusen
|
|
WO2008157740A2
(en)
|
2007-06-20 |
2008-12-24 |
Ironwood Pharmaceuticals, Inc. |
Faah inhibitors
|
|
UA110089C2
(uk)
|
2007-10-05 |
2015-11-25 |
Ак'Юсела Інк. |
Алкоксисполуки для лікування нейродегенеративних хвороб
|
|
KR101810381B1
(ko)
|
2008-02-11 |
2017-12-19 |
유니버시티 오브 워싱톤 스루 이츠 센터 포 커머셜리제이션 |
연령-관련 망막 기능장애의 치료 및 예방 방법
|
|
AU2009282076A1
(en)
|
2008-08-12 |
2010-02-18 |
Sirtris Pharmaceuticals, Inc. |
Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
|
|
JP2012520880A
(ja)
|
2009-03-17 |
2012-09-10 |
アーシエックス セラピューティックス， インコーポレイテッド |
ケトチフェンの眼科用製剤および使用方法
|
|
WO2010133672A1
(en)
|
2009-05-20 |
2010-11-25 |
Clanotech Ab |
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
US20100331315A1
(en)
|
2009-06-18 |
2010-12-30 |
Mustapha Haddach |
Rhodanines and related heterocycles as kinase inhibitors
|
|
WO2011008202A1
(en)
|
2009-07-15 |
2011-01-20 |
Vanderbilt University |
Isoketal scavengers and mitigation of disorders involving oxidative injury
|
|
CA2783699C
(en)
|
2009-12-08 |
2019-01-15 |
Case Western Reserve University |
Primary amine compounds for treating ocular disorders
|
|
CA2782015C
(en)
|
2009-12-11 |
2020-08-25 |
Neuron Systems, Inc. |
Topical ophthalmic compositions and methods for the treatment of macular degeneration
|
|
JPWO2011078204A1
(ja)
|
2009-12-24 |
2013-05-09 |
浜理薬品工業株式会社 |
高脂血症の予防または治療剤、および抗疲労剤
|
|
WO2011116066A1
(en)
|
2010-03-17 |
2011-09-22 |
Concert Pharmaceuticals, Inc. |
Derivatives of dimethylcurcumin
|
|
CN103562186B
(zh)
|
2011-01-12 |
2017-02-15 |
帆德制药股份有限公司 |
作为toll样受体调节剂的取代的苯并氮杂卓
|
|
US10463687B2
(en)
|
2011-01-20 |
2019-11-05 |
Cornell University |
Treatments for retinal disorders
|
|
EP2670439B1
(en)
|
2011-01-31 |
2019-03-13 |
PVAC Medical Technologies Ltd. |
Active principle for mitigating undesired medical conditions
|
|
TWI544922B
(zh)
|
2011-05-19 |
2016-08-11 |
愛爾康研究有限公司 |
高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
|
|
US20130190500A1
(en)
*
|
2011-12-12 |
2013-07-25 |
Neuron Systems, Inc. |
Process to prepare 6-chloro-3-amino-2-(2-hydroxypropyl)-1-azanaphthalene
|
|
US20130165419A1
(en)
|
2011-12-21 |
2013-06-27 |
Insite Vision Incorporated |
Combination anti-inflammatory ophthalmic compositions
|
|
BR112015002249A2
(pt)
|
2012-08-01 |
2017-07-04 |
Lewis And Clark Pharmaceuticals Inc |
composto, um estereoisômero ou sal farmaceuticamente aceitável do mesmo; composição farmacêutica; método para tratar um estado associado a receptor de adenosina a2a em um indivíduo; método para diagnosticar anormalidades de perfusão de miocárdio em um mamífero; e método para reduzir a pressão interocular em um indivíduo
|
|
EP4566672A3
(en)
|
2012-11-08 |
2025-08-13 |
Clearside Biomedical Inc. |
Methods for the treatment of ocular disease in human subjects
|
|
WO2014100425A1
(en)
|
2012-12-20 |
2014-06-26 |
Aldexa Therapeutics, Inc. |
Peri-carbinols
|
|
HK1217439A1
(zh)
*
|
2013-01-23 |
2017-01-13 |
Aldeyra Therapeutics, Inc. |
与毒性醛相关的疾病和治疗
|
|
HK1217490A1
(zh)
|
2013-01-25 |
2017-01-13 |
Aldeyra Therapeutics, Inc. |
黃斑變性治療中的新穎捕獲劑
|
|
US9713330B1
(en)
|
2013-03-15 |
2017-07-25 |
Deuteria Agrochemicals, Llc |
Deuterium-enriched aldehydes
|
|
EP3151818A4
(en)
|
2014-06-04 |
2018-05-30 |
Case Western Reserve University |
Compositions and methods of treating diabetic retinopathy
|
|
NO2721710T3
(enExample)
|
2014-08-21 |
2018-03-31 |
|
|
|
AU2015312134A1
(en)
|
2014-09-02 |
2017-03-23 |
Bhupinder Singh |
Deuterated or a non-deuterated molecule and pharmaceutical formulations
|
|
US10363231B2
(en)
|
2014-11-24 |
2019-07-30 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
|
CN118724806A
(zh)
|
2015-08-21 |
2024-10-01 |
奥尔德拉医疗公司 |
氘化化合物和其用途
|
|
WO2017035082A1
(en)
*
|
2015-08-21 |
2017-03-02 |
Aldeyra Therapeutics, Inc. |
Aldehyde conjugates and uses thereof
|
|
CN109069530A
(zh)
|
2016-02-28 |
2018-12-21 |
奥尔德拉医疗公司 |
用环糊精治疗过敏性眼部病状
|
|
MX2018013472A
(es)
|
2016-05-09 |
2019-02-28 |
Aldeyra Therapeutics Inc |
Tratamiento de combinacion de trastornos y enfermedades inflamatorios oculares.
|
|
WO2018039197A1
(en)
|
2016-08-22 |
2018-03-01 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and methods of use thereof
|
|
CA3032521A1
(en)
|
2016-08-22 |
2018-03-01 |
Aldeyra Therapeutics, Inc. |
Aldehyde trapping compounds and uses thereof
|
|
WO2018170476A1
(en)
|
2017-03-16 |
2018-09-20 |
Aldeyra Therapeutics, Inc. |
Polymorphic compounds and uses thereof
|